IMMX
Immix Biopharma, Inc.
Key Financials
Operating Income
$-29956415
↓ 32.1%
Revenue
$20.0M
0.0%
Total Assets
$104.8M
↑ 356.9%
Net Income
$-29438613
↓ 36.2%
Shareholders' Equity
$13.3M
↓ 19.2%
Cash & Equivalents
$93.9M
↑ 431.2%
EPS (Diluted)
$-0.89
↓ 17.1%
Total Liabilities
$11.0M
↑ 13.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IMMX |
| Company Name | Immix Biopharma, Inc. |
| CIK | 1873835 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (888) 958-1084 |